003520 — Yungjin Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Yungjin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	428	465	682	10,208	3,436
Net Total Accounts Receivable
Net Total Receivables	45,012	48,145	51,551	52,826	47,187
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	98,675	89,688	102,194	126,564	123,818
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75,779	88,435	85,640	85,319	98,013
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	188,101	194,095	203,083	226,601	234,258
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,140	48,329	49,632	75,055	114,634
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	73,669	89,210	113,213	136,968	144,455
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	114,432	104,885	89,870	89,632	89,803
Total Liabilities & Shareholders' Equity	188,101	194,095	203,083	226,601	234,258
Total Common Shares Outstanding